Further to the intimation submitted to Stock Exchanges dated July 27, 2026, with respect to the meeting of the Board of Directors of the Company, to be held on Thursday, August 06, 2026, ....

July 27, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Intimation of Earnings Call to discuss the Unaudited Financial Results of HealthCare Global Enterprises Limited (“the Company”) Stock Code : BSE – 539787, NSE – HCG Reference : R e g u lation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Further to the intimation submitted to Stock Exchanges dated July 27, 2026, with respect to the meeting of the Board of Directors of the Company, to be held on Thursday, August 06, 2026, inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30, 2026 (“Financial Results”), we would like to inform you that, an Earnings Conference Call has been scheduled on Friday, August 07, 2026, at 02.00 p.m. (IST), to discuss the Financial Results of the Company. You are requested to take the intimation on record. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag HEALTHCARE GLOBAL ENTERPRISES LIMITED HCG’s Q1 FY27 Earnings Call Friday, August 7th 2026 at 2:00 pm IST Healthcare Global Enterprises Limited (HCG), India’s largest cancer care provider under the brand “HCG”, will organize a conference call for investors and analysts on Friday, August 7th 2026 at 2:00 pm IST. The senior management of the Company will be present to address the call. The conference call will be initiated with a brief management discussion on the Q1FY27 results, to be declared on Thursday, August 6th 2026, followed by an interactive Question & Answer session. Details of the conference call are as follows: Timing : 2:00 pm IST on Friday, August 7, 2026 Pre-registration (Zero wait time : To enable participants to connect to the conference call to join the call) without having to wait for an operator, please register at the below mentioned link: Conference dial-in Primary : +91 22 6280 1141 / +91 22 7115 8042 Numbers Hong Kong Toll Free Number : 800 964 448 Singapore Toll Free Number : 800 101 2045 UK Local Number : 0 808 101 1573 USA Local Number : 1 866 746 2133 About Healthcare Global Enterprises Limited (HCG): HealthCare Global Enterprises Ltd. (HCG), headquartered in Bengaluru, is the largest provider of cancer care in India. Through its network of 25 hospitals across India and Africa, HCG has brought advanced cancer care to the doorstep of millions of people. HCG’s comprehensive cancer centers provide expertise and advanced technologies for the effective diagnosis and treatment of cancer under one roof. For updates and specific queries, please visit www.hcgel.com or feel free to contact Healthcare Global Enterprises Limited CDR India Ravi Gothwal, Head – Investor Relations Anoop Poojari / Suraj Digawalekar Ph: +91-9599655711 Ph.: +91 98330 90434 / 98211 94418 Email: ravi.gothwal@hcgel.com Email: anoop@cdr-india.com / suraj@cdr-india.com Safe Harbor This document may contain forward-looking statements about Healthcare Global Enterprises Limited and its Subsidiaries, which are based on the beliefs, opinions, and expectations of the company’ s management as the date of this Investor release and the companies do not assume any obligation to update their forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. Consequently, readers should not place any undue reliance on such forward-looking statements.